샘플 요청 목록

 카트 문의
시장보고서
상품코드
1684739

안내 렌즈 시장 : 성장, 전망, 경쟁 분석(2025-2033년)

Intraocular Lens Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033
발행일: | 리서치사: Acute Market Reports | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

안내 렌즈(IOL) 시장에는 주로 백내장 및 굴절 이상 치료에 사용되는 안과 수술용 인공수정체의 생산 및 유통이 포함됩니다. 인공수정체는 자연 수정체가 혼탁해졌을 때 이를 대체하기 위해 안구에 삽입됩니다. 이 렌즈는 근시, 원시, 난시 등의 시력 문제를 교정하고 환자의 전반적인 시력을 향상시킬 수 있습니다. 이 시장에는 단초점 렌즈, 다초점 렌즈, 토릭 렌즈, 수용 렌즈 등 다양한 유형의 안구내 렌즈가 있으며, 각 렌즈는 특정 시력 장애에 맞게 설계되어 있습니다. 안내 렌즈 시장 규모는 4.8%의 연평균 성장률(CAGR)로 성장할 것으로 예상됩니다. 이러한 성장은 주로 고령화 사회에서 흔히 볼 수 있는 눈 관련 질환, 특히 백내장의 유병률 증가에 기인합니다. 전 세계 인구 통계가 고령자 비율 증가로 이동함에 따라 백내장 수술, 나아가 안내 렌즈 수요가 크게 증가할 것으로 예상됩니다. 의료기술의 발전으로 인공수정체의 성능도 향상되고 있으며, 차세대 렌즈는 치료 결과와 환자 만족도를 향상시키고 있습니다.

안내 렌즈(IOL) 시장 성장의 주요 촉진요인은 세계 인구의 고령화입니다. 전 세계에서 평균 수명이 증가함에 따라 백내장 및 기타 노화 관련 안질환에 가장 취약한 노인의 수가 증가하고 있습니다. 백내장은 특히 노년층에서 전 세계에서 시각 장애와 실명의 주요 원인 중 하나입니다. 따라서 혼탁해진 수정체를 인공수정체로 대체하는 백내장 수술의 필요성이 높아지고 있습니다. 예를 들어 세계보건기구(WHO)에 따르면 노화에 따른 백내장은 전 세계 실명의 51%를 차지하며, 이 수치는 약 2,000만 명에 해당합니다. 인구 고령화에 따라 선명한 시력 회복을 위한 안내 렌즈 수요는 지속적으로 증가하고 있으며, 이는 시장 확대의 원동력이 되고 있습니다.

안내 렌즈 시장의 큰 기회는 안내 렌즈의 지속적인 기술 발전에 있습니다. 다초점 렌즈와 수용성 렌즈와 같은 기술 혁신으로 환자들은 안경이나 콘택트렌즈에 대한 의존도를 낮추고 수술 후 결과를 개선할 수 있게 되었습니다. 이러한 첨단 렌즈는 환자에게 근거리, 중간거리, 원거리 시력을 제공하도록 설계되어 수술 후 삶의 질을 향상시키고자 하는 소비자의 요구에 부응하고 있습니다. 또한 백내장 수술시 난시를 교정하는 토릭 렌즈의 개발은 특정 굴절 이상을 가진 환자에게 맞춤형 솔루션을 제공함으로써 시장의 저변을 넓히고 있습니다.

세계의 안내 렌즈 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 서문

제2장 개요

제3장 안내 렌즈 시장 : 경쟁 분석

제4장 안내 렌즈 시장 : 거시 분석과 시장 역학

  • 서론
  • 세계의 안내 렌즈 시장가치(2023-2033년)
  • 시장 역학
  • 촉진요인과 억제요인의 영향 분석
  • 시소 분석
  • Porter's Five Forces 모델
  • PESTEL 분석

제5장 안내 렌즈 시장 : 제품 유형별(2023-2033년)

  • 시장 개요
  • 성장과 매출 분석 : 2024년 대 2033년
  • 시장 세분화

제6장 안내 렌즈 시장 : 최종사용자별(2023-2033년)

  • 시장 개요
  • 성장과 매출 분석 : 2024년 대 2033년
  • 시장 세분화

제7장 북미의 안내 렌즈 시장(2023-2033년)

제8장 영국 및 EU 안내 렌즈 시장(2023-2033년)

제9장 아시아태평양의 안내 렌즈 시장(2023-2033년)

제10장 라틴아메리카의 안내 렌즈 시장(2023-2033년)

제11장 중동 및 아프리카의 안내 렌즈 시장(2023-2033년)

제12장 기업 개요

  • Abbott Medical Optics
  • Carl Zeiss Meditec AG
  • Bausch &Lomb Inc.
  • Alcon(Novartis AG)
  • Hoya Surgical Optics
  • PhysIOL
  • Staar Surgical Company
  • Calhoun Vision Inc.
  • Oculentis GmbH
  • Rayner Intraocular Lenses Limited
  • 기타
KSA 25.03.31

The intraocular lens (IOL) market involves the production and distribution of artificial lenses used in eye surgeries, primarily to treat cataracts and refractive errors. An intraocular lens is implanted in the eye to replace the natural lens when it becomes clouded. These lenses can also correct other vision problems, including myopia (nearsightedness), hyperopia (farsightedness), and astigmatism, enhancing the patient's overall vision. This market includes a range of IOL types, such as monofocal, multifocal, toric, and accommodative lenses, each designed to address specific visual impairments. The intraocular lens market is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.8%. This growth is primarily driven by the increasing prevalence of eye-related disorders, particularly cataracts, which commonly affect the aging population. As global demographics shift towards a higher proportion of elderly individuals, the demand for cataract surgeries and, consequently, for intraocular lenses is expected to rise significantly. Advances in medical technology have also expanded the capabilities of IOLs, with newer generations of lenses providing improved outcomes and greater patient satisfaction.

Aging Global Population

The primary driver for the growth of the intraocular lens (IOL) market is the aging global population. As life expectancy increases worldwide, the number of elderly individuals who are most susceptible to cataracts and other age-related eye disorders is rising. Cataracts are one of the leading causes of visual impairment and blindness globally, especially among the elderly. The need for cataract surgery, where the clouded natural lens is replaced with an artificial intraocular lens, thus becomes more prevalent. For instance, age-related cataract is responsible for 51% of world blindness, a figure representing about 20 million people, according to the World Health Organization. As populations age, the demand for IOLs to restore vision clarity continues to grow, driving the expansion of the market.

Technological Advancements in IOLs

A significant opportunity in the intraocular lens market lies in the ongoing technological advancements in IOLs. Innovations such as multifocal and accommodative lenses have improved post-surgical outcomes by allowing patients to rely less on glasses or contact lenses. These advanced lenses are designed to provide patients with a range of vision, from near to intermediate to far, catering to the increasing consumer demand for enhanced quality of life post-surgery. Additionally, the development of toric lenses to correct astigmatism at the time of cataract surgery is broadening the market's reach, providing tailored solutions for patients with specific refractive errors.

High Cost of Advanced IOLs

A significant restraint in the intraocular lens market is the high cost associated with advanced IOLs. Premium lenses such as multifocal and toric IOLs are often expensive, making them less accessible to patients in lower-income brackets or those without adequate insurance coverage. These costs can deter patients from opting for these advanced solutions, despite the potential benefits of reduced dependency on corrective eyewear. Additionally, in some regions, the lack of insurance coverage for premium IOLs puts them out of reach for a large segment of the population, thereby limiting market growth.

Regulatory and Safety Challenges

A major challenge in the intraocular lens market involves regulatory and safety issues. IOLs are medical devices that must meet stringent safety standards to gain regulatory approval. The process of obtaining approval from bodies like the FDA in the United States or the EMA in Europe can be lengthy and costly. Manufacturers must conduct extensive clinical trials to prove that the lenses are safe and effective. Furthermore, post-market surveillance is crucial to ensure that any long-term issues are identified and addressed. These regulatory hurdles can delay the introduction of new and innovative IOLs to the market, impacting manufacturers' ability to respond quickly to technological advancements and market demands.

Market Segmentation by Product Type

In the intraocular lens (IOL) market, product types include Monofocal IOL, Multifocal IOL, Toric IOL, Accommodative IOL, and Others. Multifocal IOLs are expected to witness the highest Compound Annual Growth Rate (CAGR) due to their ability to provide patients with the convenience of near and distance vision correction, reducing the need for glasses or contact lenses post-surgery. This type of IOL is particularly appealing in the consumer segment that prioritizes lifestyle quality and seeks freedom from corrective eyewear. Despite the higher price point of multifocal IOLs, their demand is increasing, especially in developed markets where patients are more likely to opt for premium healthcare solutions. However, Monofocal IOLs continue to generate the highest revenue within the segment. These lenses are a staple in cataract surgery due to their affordability and effectiveness in providing clear distance vision, which makes them widely accepted and commonly used across various global markets, particularly in settings with budget constraints or less access to advanced healthcare options.

Market Segmentation by End-user

Regarding end-user segmentation, the intraocular lens market is divided into Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers, and Eye Research Institutes. Hospitals are expected to account for the highest revenue due to their comprehensive healthcare services and the high volume of cataract surgeries performed in these settings. Hospitals are typically the primary centers for such surgeries given their extensive facilities and access to a broad range of ophthalmic specialists. On the other hand, Ambulatory Surgery Centers (ASCs) are projected to experience the highest CAGR. The growth in this sector is driven by the shift towards outpatient surgical care due to advancements in surgical techniques and anesthesia that allow for quicker recovery times and reduced costs. ASCs offer a convenient and cost-effective alternative to hospitals for cataract surgery, appealing to an increasing number of patients and healthcare providers alike, fostering rapid growth in this segment.

Geographic Segment

The intraocular lens (IOL) market is characterized by significant geographic variations, with Asia Pacific emerging as the region with the highest Compound Annual Growth Rate (CAGR) due to its large aging population, increasing prevalence of eye-related diseases, and expanding access to healthcare services. The rapid economic growth in countries such as China and India, coupled with improvements in healthcare infrastructure, has greatly increased the volume of cataract surgeries performed, thereby driving the demand for IOLs. In 2024, North America generated the highest revenue within the IOL market, a status attributed to the region's advanced healthcare system, high patient awareness, and the early adoption of premium IOL products such as multifocal and toric lenses. The presence of a well-established medical reimbursement framework also supports the widespread use of advanced IOLs in the United States and Canada.

Competitive Trends and Key Strategies

In 2024, the competitive landscape of the intraocular lens market was shaped by key players including Abbott Medical Optics, Carl Zeiss Meditec AG, Bausch & Lomb, Inc., Alcon (Novartis AG), Hoya Surgical Optics, PhysIOL, Staar Surgical Company, Calhoun Vision, Inc., Oculentis GmbH, Rayner Intraocular Lenses Limited, and other prominent players. These companies focused on technological innovations, expanding their product portfolios with advanced IOLs that offer improved visual outcomes and reduced dependency on glasses. For instance, Alcon introduced precision-engineered toric lenses designed to correct astigmatism at the time of cataract surgery, while Carl Zeiss Meditec AG emphasized the integration of digital technology in its lens customization processes to enhance surgical outcomes.

From 2025 to 2033, these companies are expected to intensify their focus on R&D to develop IOLs that provide even greater levels of patient satisfaction in terms of visual acuity and lifestyle compatibility. Strategic partnerships and acquisitions will likely be key strategies as firms look to expand their geographic reach and penetrate emerging markets, particularly in Asia Pacific and Latin America. Additionally, companies are anticipated to leverage digital and AI technologies more extensively to personalize IOLs to individual patient eye characteristics, thereby optimizing post-surgical outcomes. Marketing strategies will increasingly target educating patients and healthcare providers about the benefits of advanced IOL options, which could help shift consumer preferences towards these premium products even in cost-sensitive markets.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Intraocular Lens market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Intraocular Lens market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

  • Product Type
  • Monofocal IOL
  • Multifocal IOL
  • Toric IOL
  • Accommodative IOL
  • Others
  • End-user
  • Hospitals
  • Ophthalmology Clinics
  • Ambulatory Surgery Centers
  • Eye Research Institutes
  • Region Segment (2023-2033; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Intraocular Lens market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Intraocular Lens market?
  • Which is the largest regional market for Intraocular Lens market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Intraocular Lens market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Intraocular Lens market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Intraocular Lens Market
  • 2.2. Global Intraocular Lens Market, By Product Type, 2024 (US$ Million)
  • 2.3. Global Intraocular Lens Market, By End-user, 2024 (US$ Million)
  • 2.4. Global Intraocular Lens Market, By Geography, 2024 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2024

3. Intraocular Lens Market: Competitive Analysis

  • 3.1. Market Positioning of Key Intraocular Lens Market Vendors
  • 3.2. Strategies Adopted by Intraocular Lens Market Vendors
  • 3.3. Key Industry Strategies

4. Intraocular Lens Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Intraocular Lens Market Value, 2023 - 2033, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 5.3. Market Segmentation
    • 5.3.1. Monofocal IOL
    • 5.3.2. Multifocal IOL
    • 5.3.3. Toric IOL
    • 5.3.4. Accommodative IOL
    • 5.3.5. Others

6. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 6.3. Market Segmentation
    • 6.3.1. Hospitals
    • 6.3.2. Ophthalmology Clinics
    • 6.3.3. Ambulatory Surgery Centers
    • 6.3.4. Eye Research Institutes

7. North America Intraocular Lens Market, 2023-2033, USD (Million)

  • 7.1. Market Overview
  • 7.2. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
  • 7.3. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
  • 7.4.Intraocular Lens Market: By Region, 2023-2033, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 7.4.1.1.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 7.4.1.2.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 7.4.1.3.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)

8. UK and European Union Intraocular Lens Market, 2023-2033, USD (Million)

  • 8.1. Market Overview
  • 8.2. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
  • 8.3. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
  • 8.4.Intraocular Lens Market: By Region, 2023-2033, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 8.4.1.1.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 8.4.1.2.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 8.4.1.3.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 8.4.1.4.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 8.4.1.5.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 8.4.1.6.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)

9. Asia Pacific Intraocular Lens Market, 2023-2033, USD (Million)

  • 9.1. Market Overview
  • 9.2. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
  • 9.3. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
  • 9.4.Intraocular Lens Market: By Region, 2023-2033, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 9.4.1.1.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 9.4.1.2.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 9.4.1.3.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 9.4.1.4.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 9.4.1.5.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 9.4.1.6.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)

10. Latin America Intraocular Lens Market, 2023-2033, USD (Million)

  • 10.1. Market Overview
  • 10.2. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
  • 10.3. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
  • 10.4.Intraocular Lens Market: By Region, 2023-2033, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 10.4.1.1.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 10.4.1.2.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 10.4.1.3.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)

11. Middle East and Africa Intraocular Lens Market, 2023-2033, USD (Million)

  • 11.1. Market Overview
  • 11.2. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
  • 11.3. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
  • 11.4.Intraocular Lens Market: By Region, 2023-2033, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 11.4.1.1.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 11.4.1.2.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Intraocular Lens Market: By Product Type, 2023-2033, USD (Million)
        • 11.4.1.3.2. Intraocular Lens Market: By End-user, 2023-2033, USD (Million)

12. Company Profile

  • 12.1. Abbott Medical Optics
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Carl Zeiss Meditec AG
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Bausch & Lomb, Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Alcon (Novartis AG)
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Hoya Surgical Optics
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. PhysIOL
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Staar Surgical Company
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Calhoun Vision, Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Oculentis GmbH
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Rayner Intraocular Lenses Limited
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Other Prominent Players
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제